Analysis of comorbid pathology in patients with occupational chronic obstructive pulmonary disease from exposure to industrial aerosols according to the regional register of Occupational Diseases of the Novosibirsk region

Introduction. In the course of the work the scientists have conducted an analysis of comorbid pathology was carried out in patients with occupational chronic obstructive pulmonary disease (OCOPD) who underwent inpatient examination at the Clinic of the Novosibirsk Research Institute of Hygiene of Rospotrebnadzor.

The study aims to research the frequency and nature of comorbid pathology in patients with OCOPD who underwent inpatient examination at the Clinic of the Novosibirsk Research Institute of Hygiene of Rospotrebnadzor.

Materials and methods. In the course of the work we have conducted a retrospective analysis of the medical histories of patients with occupational chronic obstructive pulmonary disease who were examined and treated at the Clinic of Occupational Pathology. Researchers have carried out the analysis of the histories using the regional register of occupational diseases of Novosibirsk and the Novosibirsk Region created by the staff of the Research Institute of Hygiene and the permanent regional register of Occupational Diseases.

Results. The study made it possible to determine the structure of comorbid pathology of patients with occupational chronic obstructive pulmonary disease who were examined and treated at the Сlinic of Occupational Pathology and School-related Diseases of the Novosibirsk Research Institute of Hygiene of Rospotrebnadzor.

Conclusion. Comorbid pathology affects the severity of the patient's condition with OCOPD. We have made conclusions about the need for early diagnosis of occupational chronic obstructive pulmonary disease and its comorbid conditions, an individualized approach to each patient for effective rehabilitation.

Ethics. The material of the article was approved by the Ethics Committee at the Novosibirsk Scientific Research Institute of Hygiene of Rospotrebnadzor (Protocol No. 3 of June 16, 2022).

Contribution:
Ivashchenko I.E. — the concept and design of the study, data collection and processing, text writing, editing;
Kuzmenko M.A. — the concept and design of the study, text writing, editing;
Popova V.V. — the concept and design of the study, data collection and processing, editing;
Alexandrova I.V. — text writing.

Funding. The study had no funding.

Conflict of interests. The authors declare no conflict of interests.

Received: 14.07.2022 / Accepted: 09.09.2022 / Published: 28.09.2022

1. Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy. Seattle, WA: IHME, 2015.

2. Adeloye D., Chua S., Lee C., Basquill C., Papana A., Theodoratou E., Nair H., Gasevic D., Sridhar D., Campbell H., Chan K.Y., Sheikh A., Rudan I. Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015; 5(2): 020415. https://doi.org/10.7189/jogh.05.020415

3. Chuchalin A.G., Khaltaev N., Antonov N.S., Galkin D.V., Manakov L.G., Antonini P., Murphy M., Solodovnikov A.G., Bousquet J., Pereira M.H., Demko I.V. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014; 9: 963–74. https://doi.org/10.2147/COPD.S67283

4. Sakolchik M.A., Gorblyansky Yu.Yu., Podmogilnaya K.V., Fedyakina V.V. Epidemiological features of occupational chronic obstructive pulmonary disease. Occupational Health and Industrial Ecology. 2018; (7): 51–5. https://doi.org/10.31089/1026-9428-2018-7-51-55 (in Russian).

5. Clinical guidelines — Chronic obstructive pulmonary disease (COPD) — 2021–2022–2023 (06.23.2021) — Approved by the Ministry of Health of the Russian Federation. http://gbpokachi.ru/upload/medialibrary/cbd/ihw8fuyu7pyeyo0o24r32wn1p8wix9jy.pdf (in Russian).

6. Belevsky A.S., Vizel A.A., Zyryanov S.K., Ignatova G.L., Kolbin A.S., Leshchenko I.V., Titova O.N., Frolov M.Yu. Chronic obstructive pulmonary disease: today's problems. Prakticheskaya pul'monologiya. 2015; 3: 18–23. https://elibrary.ru/vjxbqt (in Russian).

7. Shpagina L.A., Kotova O.S., Shpagin I.S., Kuznetsova G.V., Kamneva N.V. Quality of life of patients with occupational chronic obstructive pulmonary disease depending on its phenotype. Journal of Siberian Medical Sciences. 2019; (3): 24–32. https://doi.org/10.31549/2542-1174-2019-3-24-32 (in Russian).

8. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2020: State report. Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow; 2021. https://www.rospotrebnadzor.ru/upload/iblock/5fa/gd-seb_02.06-_s-podpisyu_.pdf (in Russian).

9. Ostroumova O.D., Kochetkov A.I. Chronic obstructive pulmonary disease and comorbid cardiovascular diseases: a view from the standpoint of recommendations. Consilium Medicum. 2018; 1: 54–61. https://doi.org/10.26442/2075-1753_2018.1.54-61 (in Russian).

10. Vertkin A.L., Skotnikov A.S. Comorbidity. Lechashchiy vrach. 2013; 6: 66–9. https://www.lvrach.ru/2013/08/15435786 (in Russian).

11. Shirinsky V.S., Shirinsky I.V. Comorbid diseases are an actual problem of clinical medicine. Sibirskiy meditsinskiy zhurnal. 2014; 29(1): 7–12. https://elibrary.ru/twkltd (in Russian).

12. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2020. https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf

13. Сharlson M.E., Pompei P., Ales K.L., McKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40(5): 373–83. https://doi.org/10.1016/0021-9681(87)90171-8

14. Shpagin I.S., Kotova O.S., Pospelova T.I., Gerasimenko O.N., Shpagina L.A., Ermakova M.A. Chronic obstructive pulmonary disease in combination with essential arterial hypertension: clinical, functional and molecular genetic features. Vestnik sovremennoy klinicheskoy meditsiny. 2016; 9(4): 56–65. https://doi.org/10.20969/VSKM.2016.9(4).56-65 (in Russian).

15. Balmes J., Becklake M., Blanc P., Henneberger P., Kreiss K., Mapp C. et al. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am. J. Respir. Crit. Care Med. 2003; 167(5): 787–97. https://doi.org/10.1164/rccm.167.5.787

16. Vasilyeva O.S., Kravchenko N.Yu. Chronic obstructive pulmonary disease as an occupational disease: risk factors and the problem of medical and social rehabilitation of patients. Rossiyskiy meditsinskiy zhurnal. 2015; 21(5): 22–26. https://elibrary.ru/uixakn (in Russian).

17. Miller J., Edwards L.D., Agusti A., Bakke P. et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir. Med. 2013; 107(9): 1376–84. https://doi.org/10.1016/j.rmed.2013.05.001

18. Eisner M.D., Blanc P.D., Sidney S. et al. Body composition and functional limitation in COPD. Respir. Res. 2007; 8: 7. https://doi.org/10.1186/1465-9921-8-7

19. Vozoris N.T., O'Donnell D.E. Prevalence, risk factors, activity limitation and health care utilization of an obese populationbased sample with chronic obstructive pul monary disease. Can. Respir. J. 2012; 19: e18–e24. https://doi.org/10.1155/2012/732618

20. Samuleeva Yu.V., Zadionchenko V.S., Li V.V., Adasheva T.V., Samorukova E.I., Pikhlak A.E. Obesity and metabolic disorders in patients with chronic obstructive pulmonary disease: possibilities of phenotyping. Pul'monologiya. 2014; 5: 32–8. https://elibrary.ru/tccdbh (in Russian).